Skip to evidence report

T.CD4_transitional.baseline: Studies

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 3,605 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 1–1,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for T.CD4_transitional.baseline
#Trait / studyIndividual trait IDMean IC score
1Allergic contact dermatitisFING0000006844.10
2Psoriasis vulgaris (PheCode 696.41)GCST9047619041.17
3Psoriatic arthritisGCST9024395640.61
4Psoriasis (PheCode 696.4)GCST9047618739.74
5Psoriasis and related disorder (PheCode 696)GCST9047618639.71
6Non-cancer illness code, self-reported - hypothyroidism/myxoedema | Medical conditionsUKBB0000051839.31
7Papulosquamous disordersFING0000114439.13
8Second line medication for Crohn's diseaseFING0000128439.05
9Autoimmune diseases excluding thyroid diseasesFING0000013238.54
10Asthma | Chronic lower respiratory diseasesUKBB0000005337.88
11CD5/TNFRSF9 ratioGCST9031386237.48
12Treatment/medication code - levothyroxine sodium | MedicationsUKBB0000084937.44
13Reimbursement for rheumatic diseasesFING0000124737.42
14Asthma | respiratoryUKBB0000005437.16
15Non-cancer illness code, self-reported - eczema/dermatitis | Medical conditionsUKBB0000050936.50
16Hypothyroidism | endocrine/metabolicUKBB0000033536.24
17Other/unspecified rheumatoid arthritisFING0000112635.68
18Other hypothyroidism | Disorders of thyroid glandUKBB0000061135.66
19Hypothyroidism NOS | endocrine/metabolicUKBB0000033635.47
20CXCL9 levelsGCST9046893535.40
21Thyroid problemsGCST9047527635.38
22Hypothyroidism NOS (PheCode 244.4)GCST9047565335.33
23Hypothyroidism (PheCode 244)GCST9047564735.16
24Nasal polypFING0000085835.10
25Atopic dermatitisFING0000012534.99
26HypothyroidismGCST9046813834.37
27Asthma-related infectionsFING0000011834.16
28Rheumatoid arthritisFING0000126734.08
29Disorders of the thyroid glandFING0000046333.97
30Autoimmune diseasesFING0000013133.76
31Asthma-related acute respiratory infectionsFING0000011733.40
32HypothyroidismGCST9020416733.15
33Dermatitis and eczemaFING0000040233.10
34Prescriptions - levothyroxine | thyroid hormoneUKBB0000068732.57
35Prescriptions - thyroid hormone | hormoneUKBB0000070532.57
36Atopic dermatitisGCST9002716132.47
37FCRL6 levelsGCST9046920932.47
38PAFAH1B3 levelsGCST9047014532.26
39Type 1 diabetesGCST9000052932.11
40Hypothyroidism, strict autoimmuneFING0000065632.09
41Asthma (childhood onset)GCST00780032.04
42TNFRSF8 levelsGCST9047091531.69
43Suggestive for eosinophilic asthmaFING0000134431.44
44Treatment or medication use - levothyroxine sodium (UKB data field 20003_1141191044)GCST9004253531.20
45CD5 levelsGCST9046864130.89
46Psoriasis vulgarisFING0000122430.26
47AsthmaGCST01004230.22
48TXNL1 levelsGCST9047099330.17
49Type 1 diabetesGCST9001379130.10
50Chronic sinusitisFING0000029830.06
51Asthma (adult onset)GCST00779929.86
52Seropositive rheumatoid arthritis, strict definitionFING0000129729.81
53Noninfective enteritis and colitisFING0000088129.79
54Lymphocyte countGCST9001874229.64
55Allergic disease (asthma, hay fever or eczema)GCST00503829.54
56Asthma/COPD (KELA code 203)FING0000012129.19
57AsthmaGCST9046811229.14
58CD48/CRTAM ratioGCST9031383929.05
59EczemaGCST9046812629.01
60MS-disease / Multiple SclerosisFING0000083928.96
61Asthma (only as main-diagnosis) (more control exclusions)FING0000011428.77
62Multiple sclerosisGCST9047583328.61
63Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - None of the above | Medical conditionsUKBB0000010128.55
64Chronic lower respiratory diseasesFING0000029028.53
65Takes medication for Thyroid problems?GCST9047527728.39
66Eosinophill percentage (UKB data field 30210)GCST9046806928.20
67Other diseases of upper respiratory tractFING0000101227.89
68Eosinophill count | Blood countUKBB0000020627.52
69HypothyroidismGCST9031932027.25
70Lymphoid neoplasmsGCST9062474327.11
71First line medication for Crohn's diseaseFING0000054426.97
72Other (seronegative) rheumatoid arthritis, wideFING0000091726.93
73SKAP1 levelsGCST9047064526.80
74Eosinophill percentage | Blood countUKBB0000020726.71
75Asthma (more control exclusions)FING0000011326.71
76EndometriosisGCST9001861926.49
77Lymphoid neoplasms (somatic mutation group 2 phenocluster)GCST9062475026.48
78Lymphocyte countGCST9000231726.44
79Lymphocyte countGCST9002598426.31
80Graves disease, strict definitionFING0000059226.29
81CD160/KLRB1 ratioGCST9031373126.26
82lymphocyte (absolute count, mean, inv-norm transformed)GCST9047542626.21
83Seropositive rheumatoid arthritis, wideFING0000129826.08
84Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Asthma | Medical conditionsUKBB0000009825.99
85ThyrotoxicosisFING0000136025.98
86AsthmaGCST9001432525.98
87NCR1 levelsGCST9047000925.95
88Eosinophil percentage of white cellsGCST00460025.93
89CXCL16 levelsGCST9046892825.91
90Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Hayfever, allergic rhinitis or eczema | Medical conditionsUKBB0000010025.90
91CRTAM/VCAM1 ratioGCST9031428125.87
92Mosaic chromosomal alteration of the X chromosomeGCST9016528725.54
93Eosinophil countGCST00460625.50
94Respiratory disease (confirmatory factor analysis Factor 11)GCST9030934525.26
95Crohn disease (strict definition, require KELA, min 2 HDR)FING0000036625.18
96Allergic asthma (mode)FING0000006625.12
97Eosinophil countGCST9000229925.01
98PDCD1 levelsGCST9047018124.90
99Non-cancer illness code, self-reported - asthma | Medical conditionsUKBB0000050624.88
100eosinophil (absolute count, mean, inv-norm transformed)GCST9047529124.87
101lymphocyte (absolute count, maximum, inv-norm transformed)GCST9047542324.86
102Type 1 diabetesGCST9001402324.81
103Eosinophil countGCST9001873324.77
104Eosinophill count (UKB data field 30150)GCST9046806824.76
105Eosinophil percentage of white cellsGCST9000238224.70
106eosinophil (fraction, mean, inv-norm transformed)GCST9047530024.62
107Eosinophil percentage of granulocytesGCST00461724.44
108HyperthyroidismGCST9046813624.36
109eosinophil (fraction, maximum, inv-norm transformed)GCST9047529724.22
110Rheumatoid arthritisGCST9001869024.17
111eosinophil (absolute count, maximum, inv-norm transformed)GCST9047528824.07
112Lymphoid neoplasms (drug group 1 phenocluster)GCST9062474023.97
113Sum eosinophil basophil countsGCST00462423.84
114CD244/CRTAM ratioGCST9031376323.78
115AsthmaGCST00686223.73
116Primary biliary cholangitisGCST9006144023.72
117Rash and other nonspecific skin eruption (PheCode 687.1)GCST9047616723.65
118Thyrotoxicosis with diffuse goitreFING0000136123.62
119Thyroid peroxidase antibody levels in pregnancyGCST9043520123.61
120GZMA/GZMB ratioGCST9031500723.57
121Eosinophil countGCST9000229823.54
122CRTAM/FCRL6 ratioGCST9031427423.49
123lymphocyte (absolute count, minimum, inv-norm transformed)GCST9047542923.44
124eosinophil (fraction, minimum, inv-norm transformed)GCST9047530323.39
125Eosinophil countGCST9000238123.36
126Neutrophil percentage of granulocytesGCST00462323.19
127PDCD1/TNFRSF8 ratioGCST9031561023.14
128Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)FING0000075623.13
129Type1 diabetes, definitions combined, early onsetFING0000138423.12
130PsoriasisGCST9001901623.09
131Asthma and allergyFING0000011522.95
132ITGAL levelsGCST9046963722.91
133eosinophil (absolute count, minimum, inv-norm transformed)GCST9047529422.89
134PAG1 levelsGCST9047014722.80
135Lymphoid neoplasms (B-cell phenocluster)GCST9062473622.72
136CD6 levelsGCST9046864422.59
137CD8A levelsGCST9046865522.58
138GZMB levelsGCST9046942422.57
139Rheumatoid arthritisGCST9013222422.50
140Childhood asthma (age<16) (more control exclusions)FING0000027022.44
141PsoriasisFING0000122222.18
142Nasal polyps (PheCode 471)GCST9047601922.16
143Basal cell carcinoma (MTAG)GCST9013741122.11
144Pulmonary fibrosisGCST9001868822.07
145CD160 levelsGCST9046859921.89
146MZB1 levelsGCST9046998721.87
147Inflammatory bowel disease, strict (require KELA)FING0000067521.82
148HyperthyroidismGCST9031931921.70
149PolyarthropathiesFING0000118021.62
150GZMH levelsGCST9046942521.60
151Thyroid peroxidase antibody positivity in pregnancyGCST9043520221.53
152Allergy/adverse effect of penicillin | injuries & poisoningsUKBB0000002821.45
153Lymphocyte count | Blood countUKBB0000041121.36
154Lymphocyte count (UKB data field 30120)GCST9046808221.35
155Seborrheic dermatitis (PheCode 690.1)GCST9047617121.34
156Hypothyroidism, drug reimbursementFING0000065521.32
157PALM2 levelsGCST9047015221.28
158IL15 levelsGCST9046955621.25
159Atopic/contact dermatitis due to other or unspecified (PheCode 939)GCST9047628921.16
160Erythematosquamous dermatosis (PheCode 690)GCST9047617021.14
161KLRB1 levelsGCST9046970921.07
162Type 1 diabetes, definitions combinedFING0000138021.07
163Rheumatoid arthritisGCST9013222321.03
164Lymphocyte countGCST9000238821.01
165Non-cancer illness code, self-reported - hayfever/allergic rhinitis | Medical conditionsUKBB0000051320.96
166Ceramide (d18:2/22:0) levelsGCST9002468220.85
167Lymphocyte countGCST9000231620.74
168GNLY levelsGCST9046937220.66
169GZMA/GZMH ratioGCST9031500820.54
170CD160/CXCL16 ratioGCST9031372820.51
171CRTAM/LY9 ratioGCST9031427820.44
172Wheeze or whistling in the chest in last year | BreathingUKBB0000091220.42
173HLAE/IL15 ratioGCST9031506120.29
174IDO1 levelsGCST9046950620.28
175Coeliac diseaseGCST9046812020.27
176Graves' disease (PheCode 242.1)GCST9047564420.26
177Lichen simplex chronicus and prurigoFING0000072520.21
178CLC levelsGCST9046876220.11
179Left-hemisphere dorsal attention network to amygdala white-matter structural connectivityGCST9030270620.11
180Infective dermatitisFING0000067320.10
181Graves' diseaseGCST9001862720.07
182OSMR levelsGCST9047013219.93
183CCL17/PDGFB ratioGCST9031368819.89
184Eosinophil countGCST9002598719.87
185Nasal polyps | respiratoryUKBB0000049419.80
186Operation code - tonsillectomy +/- adenoids | OperationsUKBB0000056719.70
187Lymphocyte countGCST00462719.69
188Acute upper respiratory infectionsFING0000003419.67
189Pain type(s) experienced in last month - Pain all over the body | PainUKBB0000063219.61
190KLRF1 levelsGCST9046971219.59
191Lichen sclerosus et atrophicusFING0000072319.46
192Systemic lupus erythematosusGCST9001186619.33
193Doctor diagnosed hayfever or allergic rhinitis | Medical informationUKBB0000019219.29
194PsoriasisGCST9046814719.25
195CD5/IL16 ratioGCST9031386119.09
196LTA levelsGCST9046981318.76
197Lichen ruber planus, wide definition including periferal and oral lichen planusFING0000072218.72
198RPE levelsGCST9047049518.67
199Sicca syndrome [Sjögren]FING0000130418.67
200SIT1 levelsGCST9047064418.52
201Inflammatory bowel disease and other gasteroenteritis and colitis (PheCode 555)GCST9047606518.28
202Thyroid peroxidase antibody positivity with euthyroid in pregnancyGCST9043520318.26
203Vanillactate levelsGCST9019997818.26
204Neurofibromatosis, type 2FING0000086718.25
205SH2B3/TBL1X ratioGCST9031584118.16
206Monoclonal gammopathy of undetermined significanceGCST9062474518.15
207AsthmaGCST9047602418.13
208CD79B/TNFRSF4 ratioGCST9031390318.11
209Diseases of hair and hair follicles (PheCode 704)GCST9047620918.10
210Vitamin B12 deficiency anaemiaFING0000144118.10
211DNAJC21 levelsGCST9046901618.06
212AsthmaGCST9047525918.02
213Personal history of allergy to drugs, medicaments and biologocal substances | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB0000064117.99
214Obesity related asthmaFING0000089717.97
215DermatitisFING0000040117.94
216HayfeverGCST9046813117.92
217IL2RB levelsGCST9046958617.90
218TNFRSF17 levelsGCST9047090817.82
219Handedness (chirality/laterality) - Left-handed | Early life factorsUKBB0000030217.80
220GZMB/IL15 ratioGCST9031501517.78
221Autoimmune hyperthyroidismFING0000013417.68
222Blood cell traits latent factor 20 (red cell)GCST9055926217.65
223Age hay fever, rhinitis or eczema diagnosed | Medical conditionsUKBB0000001517.60
224Blood cell traits latent factor 17 (white cell)GCST9055925917.57
225HSIL lesion of the cervix uteriFING0000062417.57
226CD244/FCRL6 ratioGCST9031376517.47
227RBFOX3 levelsGCST9047043217.47
228CD160/NCR1 ratioGCST9031373217.46
229Nasal polyp | Other diseases of upper respiratory tractUKBB0000049317.44
230CD7 levelsGCST9046864917.34
231Seronegative rheumatoid arthritisFING0000129617.22
232ChalazionFING0000026717.15
233Left-hemisphere control network to amygdala white-matter structural connectivityGCST9030275717.11
234IridocyclitisFING0000069617.03
235CRTAM levelsGCST9046887117.01
236ATOX1/SNAP29 ratioGCST9031337417.01
237Coeliac diseaseFING0000031216.99
238Crohn's disease NASFING0000036716.97
239Mouth/teeth dental problems - None of the above | MouthUKBB0000048916.96
240IL15/IL18BP ratioGCST9031514816.91
241Wheeze or whistling in the chest in last year (UKB data field 2316)GCST9004361416.79
242IFNG levelsGCST9046951516.75
243Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)GCST9013222716.74
244Blood cell traits latent factor 9 (white cell)GCST9055925116.73
245SarcoidosisGCST9050348316.64
246Blood cell traits latent factor 23 (white cell)GCST9055926516.53
247Mouth/teeth dental problems - Mouth ulcers | MouthUKBB0000048816.41
248X-21285 levelsGCST9020057616.36
249Asthma with exacerbation (PheCode 495.2)GCST9047602516.22
250Type 1 diabetesGCST9043206616.22
251GNLY/GZMA ratioGCST9031494916.18
252GRAP2/SRC ratioGCST9031498916.17
253MAVS/TBL1X ratioGCST9031539916.16
254Smoking status (weighted GWA)GCST9026730316.15
255Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)FING0000114316.10
256Inflammatory bowel diseaseGCST9043218216.04
257S100A11/S100A12 ratioGCST9031579815.98
258Seborrhoeic dermatitisFING0000128215.97
259ICD10 O60: Preterm labor and deliveryGCST9045424215.95
260HippSubfield lh volume GC-ML-DG-headGCST9000267915.90
261DTI TBSS L3 Cingulum hippocampus RGCST9038456015.89
262CC2D1A/STAMBP ratioGCST9031366415.88
263Early-onset myasthenia gravisGCST9009346515.87
264Basal cell carcinoma (PheCode 172.21)GCST9047558215.73
265ICD10 N84: Polyp of female genital tractGCST9045421615.68
266Cancer of urinary organs (incl. kidney and bladder) (PheCode 189)GCST9047559315.65
267Skin cancerGCST9047557515.56
268HSIL lesion of the cervix uteri, vagina or vulvaFING0000062515.51
269Other demyelinating diseases of the central nervous systemFING0000099515.39
270Myasthenia gravisGCST9043215615.35
271DTI TBSS L1 Cingulum cingulate gyrus LGCST9038446315.31
272CD27/TGFBR2 ratioGCST9031377615.30
273Primary biliary cholangitis (PBC)FING0000121115.29
274Rheumatoid arthritisGCST00067915.23
275Attendance/disability/mobility allowance - None of the above | Other sociodemographic factorsUKBB0000005915.14
276COPD/asthma/ILD related infectionsFING0000035314.97
277Regional enteritis (PheCode 555.1)GCST9047606614.93
278Primary biliary cholangitisGCST00312914.79
279IL1RL1 levelsGCST9046957414.67
280IL5RA/TNFRSF13B ratioGCST9031516414.63
281HippSubfield lh volume Hippocampal-tailGCST9000266814.63
282Paraproteinemia (PheCode 270.32)GCST9047571014.53
283N-acetyl-2-aminoadipate levelsGCST9020026814.48
284CD27/NBL1 ratioGCST9031377414.43
285CD8 on Effector Memory CD8+ T cellGCST9000205614.42
286BMP7 levelsGCST9008815714.40
287CD48/FCRL6 ratioGCST9031384014.39
288IFI30 levelsGCST9046950914.38
289Medication use (drugs affecting bone structure and mineralization)GCST9001877314.36
290Other noninfective gastroenteritis and colitisFING0000107714.31
291KLF4 levelsGCST9046969414.30
292Atopic dermatitisGCST9001856414.25
293CXCL10 levelsGCST9046892314.20
294Interpolated Year when non-cancer illness first diagnosed | Medical conditionsUKBB0000037114.18
295Prescriptions - tramadol | opioid analgesic,selective serotonin re-uptake inhibitor,norepinephrine re-uptake inhibitorUKBB0000070614.18
296Prescriptions - opioid analgesic|selective serotonin re-uptake inhibitor|norepinephrine re-uptake inhibitorUKBB0000069414.18
297Takes medication for Skin condition (ex. Eczema, Psoriasis)?GCST9047527514.08
298KLRK1 levelsGCST9046971313.99
299CD27/DLL1 ratioGCST9031377113.98
300PDCD5 levelsGCST9047018213.97
301CD101 levelsGCST9046859613.97
302Prescriptions - albuterol | beta2-agonist,bronchodilator,asthmaUKBB0000065813.95
303Prescriptions - beta2-agonist|bronchodilator|asthmaUKBB0000067013.95
304Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050239613.95
305Peripheral or central vertigo (PheCode 386.2)GCST9047590713.89
306CRTAM/ICAM3 ratioGCST9031427613.86
307Dermatomycosis (PheCode 110.2)GCST9047556513.85
308Poisoning by antibiotics | injuries & poisoningsUKBB0000065313.85
309Asthma-related pneumoniaFING0000011913.83
310Ulcerative colitisGCST00413313.81
311Erythematous conditions (PheCode 695)GCST9047617713.80
312Systemic connective tissue disordersFING0000135013.76
313Rosacea (PheCode 695.3)GCST9047617813.71
314CCL19 levelsGCST9046857113.70
315SarcoidosisFING0000127513.70
316Other non-epithelial cancer of skin (PheCode 172.2)GCST9047558013.59
317aparc-a2009s rh thickness G-temporal-middleGCST9000371413.57
318BCL2 levelsGCST9046843313.54
319Acute pancreatitisFING0000002713.45
320PollinosisGCST9001868313.40
321Asthma, unspecified (mode)FING0000012013.39
322Blood cell traits latent factor 12 (red cell)GCST9055925413.37
323HippSubfield lh volume CA4-headGCST9000268213.35
324Crohn's disease of small intestineFING0000036913.31
325Ulcerative colitis (PheCode 555.2)GCST9004415513.29
326Pollen allergyFING0000117613.28
327PRG3 levelsGCST9047032313.26
328Lymphocyte percentage (UKB data field 30180)GCST9046808313.24
329Allergic rhinitisFING0000007113.22
330T1 FreeSurfer aseg MaskVol-to-eTIVGCST9038419213.21
331aseg lh volume HippocampusGCST9000262413.17
332MAPRE3 levelsGCST9046985913.14
333LTA4H levelsGCST9046981213.12
334Lymphocyte percentage | Blood countUKBB0000041213.12
335Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complicationsGCST9009311313.06
336IGLC2 levelsGCST9046953612.93
337Preterm labour and deliveryFING0000120912.92
338ACYP1 levelsGCST9046821412.92
339Percentage of monosialylation of core-fucosylated monogalactosylated structures without bisecting GlcNAc (GP41)GCST9066848512.90
340CXCL16/NOTCH1 ratioGCST9031433912.90
341CCL8 levelsGCST9042234612.88
342MZB1/TNFRSF13B ratioGCST9031550912.86
343SRP14 levelsGCST9047074212.85
344TRAF2/WWP2 ratioGCST9031594312.83
345Celiac disease (PheCode 557.1)GCST9004415812.80
346CRTAP levelsGCST9046887212.79
347CRTAM/TNFRSF9 ratioGCST9031428012.78
348Treatment/medication code - ventolin 100micrograms inhaler | MedicationsUKBB0000086012.77
349ELOA/POLR2F ratioGCST9031464312.76
350CALCOCO1/IRAG2 ratioGCST9031360412.70
351DTI TBSS MD Superior corona radiata LGCST9038459712.68
352Omega-3 fatty acids to total fatty acids percentageGCST9050246012.67
353Ceramide (d18:2/24:1) levelsGCST9002468412.65
354PRG2 levelsGCST9047032212.62
355Lymphocyte percentage of white cellsGCST9000238912.60
356Chronic lymphocytic leukemiaGCST9062473812.60
357SNRPB2 levelsGCST9047069712.59
358IL22 levelsGCST9046958212.59
359Taking other prescription medications | MedicationUKBB0000081312.57
360FOXO3/SH2B3 ratioGCST9031488112.57
361FCRL5/LY96 ratioGCST9031480312.55
362IL18 levelsGCST9042841112.54
363Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)FING0000077712.53
364Ulcerative colitis (strict definition, require KELA, min 2 HDR)FING0000138812.53
365ENO2/RWDD1 ratioGCST9031466712.52
366Neutrophils and lymphocytes in blood (confirmatory factor analysis Factor 35)GCST9030936912.52
367Blood cell traits latent factor 3 (white cell)GCST9055924512.42
368FUT8/TNFSF14 ratioGCST9031489512.42
369Neoplasm of uncertain behavior of skin (PheCode 173)GCST9047558512.39
370BLNK levelsGCST9046844812.34
371PPP1R2/TBL1X ratioGCST9031572012.31
372CRTAM/PDCD1 ratioGCST9031427912.28
373GZMA/TNFRSF8 ratioGCST9031501412.25
374Rheumatoid arthritis | musculoskeletalUKBB0000075712.17
375DCTN1/TRIAP1 ratioGCST9031443412.14
376Right-hemisphere dorsal attention network to amygdala white-matter structural connectivityGCST9030281112.13
377Non-albumin protein levelsUKBB0000050312.12
378Acute renal failureFING0000003012.09
379Melanomas of skin, dx or hx (PheCode 172.1)GCST9047557712.06
380STX6 levelsGCST9047077412.06
381Lymphoid neoplasms (P-cell phenocluster)GCST9062473712.05
382CRTAM/GZMA ratioGCST9031427512.04
383Primary sclerosing cholangitisGCST00403012.03
384APBB1IP/POLR2F ratioGCST9031330012.03
385CD244 levelsGCST9046861111.99
386Disorders of sclera, cornea, iris and ciliary bodyFING0000045811.95
387Ulcerative rectosigmoiditisFING0000139411.93
388HippSubfield lh volume Whole-hippocampusGCST9000268911.93
389ICD10 N97.8: Female infertility of other originGCST9045422511.90
390CA1/HMBS ratioGCST9031357311.89
391Basal cell carcinomaGCST9001341011.83
392CCL17/CD69 ratioGCST9031368411.81
393LAT/LYN ratioGCST9031528311.77
394Ulcerative colitisGCST9044679511.76
395CXCL16 levelsGCST9024052411.76
396Ulcerative colitisGCST9001871311.74
397MPHOSPH8/USP8 ratioGCST9031547911.72
398PDCD1/TNFRSF4 ratioGCST9031560911.63
399Disorders of orbitFING0000044911.63
400FCRL6/GZMA ratioGCST9031480611.62
401Urine N-acetylglutamate levels in chronic kidney diseaseGCST9026556911.59
402ConjunctivitisFING0000034611.58
403Squamous cell carcinoma (PheCode 172.22)GCST9047558311.56
404CD27/NECTIN4 ratioGCST9031377511.52
405Mean corpuscular hemoglobin concentrationGCST9001874511.50
406KDM3A levelsGCST9046967111.41
407Cervical cancerGCST9001181611.40
408Cervicalgia (PheCode 761)GCST9047626711.39
409lymphocyte (fraction, minimum, inv-norm transformed)GCST9047543811.35
410DTI TBSS L3 Sagittal stratum LGCST9038455511.35
411Chromatiales abundance in stoolGCST9003231811.30
412Multiple myeloma or monoclonal gammopathy of undetermined significanceGCST9062474611.29
413HSPA1A levelsGCST9046948711.28
414lymphocyte (fraction, mean, inv-norm transformed)GCST9047543511.24
415LBR/LGALS8 ratioGCST9031529411.19
416Plasma ascorbic acid 2-sulfate levels in chronic kidney diseaseGCST9026483211.18
417GZMA/TNFRSF4 ratioGCST9031501311.17
418LHPP levelsGCST9046976811.15
419DNMBP/WWP2 ratioGCST9031452211.05
420Psoriatic arthropathiesFING0000122510.99
421Overweight, obesity and other hyperalimentation | endocrine/metabolicUKBB0000062210.98
422DTI autoptx L2 slf l tractGCST9038518710.96
423NBN levelsGCST9047000210.96
424DKK1/IPCEF1 ratioGCST9031447110.91
425Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)FING0000077210.90
426Other and unspecified tonsillitisFING0000095410.90
427Nasal polypsGCST9046814310.88
428Frequency of stair climbing in last 4 weeks | Physical activityUKBB0000026610.84
429CEP43/MPHOSPH8 ratioGCST9031401910.83
430Dissociative [conversion] disordersFING0000046810.81
431Crohn's diseaseGCST9044679310.81
432Ulcerative colitisGCST9047532210.74
433Late-onset myasthenia gravisGCST9009346610.74
434CD6/EZR ratioGCST9031389010.65
435DNA methylation PhenoAge accelerationGCST9001429210.63
436Plasma taurocholenate sulfate* levels in chronic kidney diseaseGCST9026604010.61
437Rheumatoid arthritis and other inflammatory polyarthropathies | musculoskeletalUKBB0000075810.54
438PAXX levelsGCST9047016110.53
439SMPD3 levelsGCST9047068510.53
440NELL2/SEZ6L ratioGCST9031553610.52
441DTI autoptx MD cgc l tractGCST9038522410.52
442CD74/NPDC1 ratioGCST9031389510.49
443Rhodanobacter abundance in stoolGCST9003253610.46
444lymphocyte (fraction, maximum, inv-norm transformed)GCST9047543210.46
445GRHPR levelsGCST9046940010.44
446CEACAM8/PGLYRP1 ratioGCST9031400310.43
447SH2D1A levelsGCST9047061710.37
448Ceramide (d18:2/22:0) levelsGCST9002405410.37
449F2R/SNX9 ratioGCST9031473610.35
450APRT levelsGCST9046834510.32
451ATP5IF1/LYN ratioGCST9031338910.31
452Ratio of bis-allylic bonds to double bonds in lipidsGCST9013274410.27
453PM: initial answer - Orange circle| Prospective memoryUKBB0000065210.27
454Skin cancerGCST9047518910.26
455Other specified disorders of external earFING0000110410.23
456Infections of the skin and subcutaneous tissueFING0000067010.21
457IPCEF1/SERPINE1 ratioGCST9031518410.18
458Crohn's diseaseGCST00413210.17
459BACH1/CD2AP ratioGCST9031343510.17
460Avoided activities or situations because of previous stressful experience in past month | Traumatic eventsUKBB0000008310.17
461Lymphoid leukemia, chronic (PheCode 204.12)GCST9047561310.17
462Poultry consumptionGCST9013299610.16
463Chronic dermatitis due to solar radiation (PheCode 938.2)GCST9047628810.14
464ERBIN/LYN ratioGCST9031469410.13
465Omega-3 fatty acids to total fatty acids percentageGCST9050244810.10
466Acute upper respiratory infections of multiple and unspecified sitesFING0000003510.05
467EZR levelsGCST9046916210.05
468CRACR2A/LBR ratioGCST9031422810.01
469ATP5IF1/METAP1D ratioGCST9031339110.01
470GRAP2/MAP4K5 ratioGCST903149829.98
471Cerebrospinal fluid methylmalonate (MMA) levelsGCST903182439.98
472SH3GLB2 levelsGCST904706219.97
473PTPRC levelsGCST904703809.92
474GZMH/KLRD1 ratioGCST903150169.81
475TIGIT levelsGCST904708659.81
476FUT8/RSPO1 ratioGCST903148919.77
477ROR1/THBD ratioGCST903157869.76
478Bipolar disorderGCST0037249.72
479Other acute lower respiratory infectionsFING000009219.68
480Allergic conjunctivitisFING000000679.67
481Mean corpuscular hemoglobin concentrationGCST900023299.66
482RILP levelsGCST904704719.64
483CD48/SLAMF7 ratioGCST903138429.62
484Handedness (chirality/laterality) - Right-handed | Early life factorsUKBB000003039.59
485C9 Carnitine levels in chronic kidney diseaseGCST902576829.59
486SUMF1 levelsGCST904707839.58
487Diseases of the digestive systemFING000004299.57
488CataractsGCST900185949.54
489TPSAB1 levelsGCST904709519.53
490CD27 levelsGCST904686159.49
491Crohn's diseaseGCST904753189.47
492T1 FreeSurfer BA lh BA2 exvivo volumeGCST903855349.45
493CD48 levelsGCST904686359.44
494PSAPL1 levelsGCST902423549.44
495GBP4 levelsGCST904693139.40
496PCBD1 levelsGCST904701669.39
497Non-allergic asthma (mode) (more control exclusions)FING000008699.39
498CXCL11/DKK1 ratioGCST903143349.36
499MAP2K1 levelsGCST904698519.36
500B2M levelsGCST904684099.36
501Basophil countGCST900022939.35
502ICD10 N87: Dysplasia of cervix uteriGCST904542189.34
503MelanomaGCST900118099.34
504IL2RA levelsGCST904695859.32
505Dizziness and giddiness (Light-headedness and vertigo) (PheCode 386.9)GCST904759089.32
506Lymphocyte percentage of white cellsGCST0046329.31
507DNAJB14 levelsGCST904272359.31
508Idiopathic pulmonary fibrosisFING000006599.29
509Diseases of white blood cells (PheCode 288)GCST904758129.29
510CDSN/LY6D ratioGCST903139979.28
511ALB/Globulin ratioUKBB000000209.28
512IDP dMRI TBSS OD Posterior limb of internal capsule RGCST900044209.27
513Crohns diseaseGCST904681219.24
514Treatment speciality of consultant (recoded) - Trauma & orthopaedics | Summary AdministrationUKBB000008379.24
515Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST906685249.22
516TNFRSF11A levelsGCST902776449.21
517Left-hemisphere salience/ventral attention network to amygdala white-matter structural connectivityGCST903027249.20
518EDAR/LAT2 ratioGCST903145829.18
519Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classifiedFING000004329.17
520Rheumatoid arthritis (PheCode 714.1)GCST904762309.16
521CAPG levelsGCST904685379.13
522BACH1/SNAP23 ratioGCST903134469.10
523HEXIM1/TBL1X ratioGCST903150539.10
524GZMA/LTA ratioGCST903150129.09
525IL15/NCR1 ratioGCST903151509.09
526mean corpuscular hemoglobin (MCH, mean, inv-norm transformed)GCST904754449.08
527DNA methylation-estimated granulocyte proportionsGCST900142879.06
528IL10 levelsGCST904695469.03
529X-11550 levelsGCST902436489.03
530Benign leiomyoma with endometriosis (controls excluding all cancers)FING000001459.03
531IPCEF1 levelsGCST904696249.00
532Principal component-derived dietary pattern 9GCST901330149.00
533ARG1 levelsGCST904683508.99
534GZMA levelsGCST904694238.97
535NECTIN2/NPDC1 ratioGCST903155288.97
536Degenerative skin conditions and other dermatoses (PheCode 702)GCST904762028.96
537Mood swings | Mental healthUKBB000004828.95
538MAP2K6/TBL1X ratioGCST903153788.95
539Eye autorefraction and astigmatism (confirmatory factor analysis Factor 24)GCST903093588.91
540PEAR1/PECAM1 ratioGCST903156418.90
541Mean reticulocyte volume | Blood countUKBB000004518.90
542Never eat wheat vs no wheat restrictions (UKB data field 6144)GCST901329328.90
543PLXNB3/SNAP23 ratioGCST903156938.89
544SMNDC1 levelsGCST904706818.88
545PPM1B levelsGCST904702968.86
546SELPLG levelsGCST904705688.85
547Melanomas of skin (PheCode 172.11)GCST904755788.84
548PBLD levelsGCST904701638.83
549Obesity | endocrine/metabolicUKBB000005448.82
550FCRL5/TNFRSF13B ratioGCST903148058.75
551Autoimmune hepatitisGCST900185658.73
552Actinic keratosis (PheCode 702.1)GCST904762048.73
553CALCOCO1/TBC1D5 ratioGCST903136108.72
554Obesity | Obesity and other hyperalimentationUKBB000005458.72
555Ulcerative enterocolitisFING000013918.72
556DAG1/F2R ratioGCST903143748.71
557IDP dMRI ProbtrackX L1 ifo rGCST900042598.69
558Average total household income before tax | HouseholdUKBB000000818.69
559TALDO1 levelsGCST904708028.67
560mean corpuscular volume (MCV, minimum, inv-norm transformed)GCST904754748.67
561Mouth/teeth dental problems - Bleeding gums | MouthUKBB000004858.64
562Thoracic or lumbosacral neuritis or radiculitis, unspecified (PheCode 763)GCST904762688.64
563HippSubfield lh volume Whole-hippocampal-bodyGCST900026878.61
564Number of attempts | Prospective memoryUKBB000005318.60
565Biological Sibling: AsthmaGCST904763728.59
566LY6D/WFDC12 ratioGCST903153468.59
567GFRA2 levelsGCST904693298.57
568Lumbar disc prolapseFING000007358.57
569LBR/POLR2F ratioGCST903152978.57
570TSC1 levelsGCST904709728.57
571Psoriasis (vulgaris), strict definitionFING000012238.56
572MSRA/PRDX5 ratioGCST903154978.56
573DTI autoptx L3 ifo l tractGCST903852058.55
574Nonspecific chest pain | circulatory systemUKBB000005278.54
575SPINK2 levelsGCST904707228.50
576Alcohol-induced chronic pancreatitisFING000000558.49
577Lung cancerGCST900186558.48
578INPP5J levelsGCST904696188.48
579T1 FreeSurfer DK rh supramarginal volumeGCST903857878.48
580CD27/TNFRSF9 ratioGCST903137788.47
581TP53BP1 levelsGCST904709368.45
582CDA levelsGCST904686608.42
583Long-standing illness, disability or infirmity | General healthUKBB000004098.41
584ARHGAP25/RNF41 ratioGCST903133458.40
585Other arthritis (FG)FING000009648.38
586IL32 levelsGCST904695918.37
587aparc-a2009s rh thickness G-oc-temp-med-LingualGCST900036988.37
588ENO2/PLXNA4 ratioGCST903146658.35
589RAP1A levelsGCST904704258.35
590Myasthenia gravisGCST900930618.33
591Ankylosing spondylitis, strict definitionFING000000908.32
592CDSN/WFDC12 ratioGCST903139998.29
593Right-hemisphere somatomotor network to amygdala white-matter structural connectivityGCST903027998.29
594CEP85 levelsGCST904687168.27
595DTI TBSS MD Superior longitudinal fasciculus RGCST903846128.27
596FCRL5/ICAM3 ratioGCST903148028.26
597Mean reticulocyte volumeGCST900259758.26
598Hair colour (natural, before greying): Red (UKB data field 1747_2)GCST900418378.25
599Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)FING000001438.23
600Prescriptions - antispasmodicUKBB000006668.20
601Prospective memory result | Prospective memoryUKBB000007138.20
602IL5RA levelsGCST904696008.19
603IDP dMRI TBSS L1 Posterior limb of internal capsule RGCST900040938.18
604Multiple myelomaGCST906247478.18
605CDH17/PTPRM ratioGCST903139438.16
606MICB_MICA/TEK ratioGCST903154468.15
607CD27/CD79B ratioGCST903137708.12
608Basal cell carcinoma, excluding all cancers (controls excluding all cancers)FING000001428.11
609Other systemic involvement of connective tissue (FG)FING000011168.11
610SNAP23/TBL1X ratioGCST903158568.10
611mean corpuscular volume (MCV, mean, inv-norm transformed)GCST904754708.10
612Treatment/medication code - ibuprofen | MedicationsUKBB000008478.10
613HippSubfield lh volume CA4-bodyGCST900026838.08
614mean corpuscular volume (MCV, maximum, inv-norm transformed)GCST904754668.08
615Interpolated Age of participant when non-cancer illness first diagnosed | Medical conditionsUKBB000003698.06
616Pain in throat and chest | Symptoms and signs involving the circulatory and respiratory systemsUKBB000006257.99
6173-methyl-2-oxobutyrate levelsGCST901996777.99
618FOXO1/NFATC1 ratioGCST903148737.99
619Other contact dermatitisFING000009907.98
620Vertiginous syndromes and other disorders of vestibular system (PheCode 386)GCST904759057.98
621Spondylopathies (FG)FING000013267.98
622Chronic diseases of tonsils and adenoidsFING000002837.96
623TNF/TNFRSF1B ratioGCST903159427.95
624mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)GCST904754487.95
625Juvenile rheumatoid arthirtisFING000007067.95
626Never eat wheat vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144)GCST901329317.94
627UGDH levelsGCST904710067.94
628Thyrotoxicosis with or without goiter (PheCode 242)GCST904756437.93
629AHSP/HMBS ratioGCST903132177.93
630PM: initial answer - Blue square | Prospective memoryUKBB000006517.92
631LCN2/S100A12 ratioGCST903153097.91
632Sporadic miscarriageGCST0118887.90
633Ankylosing spondylitisFING000000897.90
634ITGB1BP2/TIA1 ratioGCST903152227.90
635MED18/TBL1X ratioGCST903154157.89
636T1 FreeSurfer aseg Right-choroid-plexusGCST903841707.89
637AHCY/HSPA1A ratioGCST903132117.89
638T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78)GCST903206417.88
639Symptoms involving digestive system (PheCode 561)GCST904760697.88
640CWC15 levelsGCST904689207.87
641Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)FING000007647.86
642PRKAR1A/SNAP23 ratioGCST903157287.84
643Other circulatory problemGCST904752177.81
644BTN3A2 levelsGCST904684817.80
645MICB or MICA levelsGCST904699057.79
646CCR2 on CD14+ CD16- monocyteGCST900020047.79
647HMBS/PKLR ratioGCST903150637.78
648GBP1 levelsGCST904693117.78
649CDH17/PECAM1 ratioGCST903139427.78
650Chronic hepatitis B infectionGCST900185847.76
651Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)FING000008467.75
652HEXIM1/TRIAP1 ratioGCST903150547.73
653DTI autoptx MD str r tractGCST903852447.71
654C5 levelsGCST904685007.70
655Bread type: Wholemeal/wholegrain vs white and brown (UKB data field 1448)GCST901329687.69
656Hypoplasia of dental enamel, including avohilmoFING000006527.68
657Disorders of plasma protein metabolism (PheCode 270.3)GCST904757097.67
658BCR/FOXO1 ratioGCST903134907.66
659ZNF830 levelsGCST904711027.64
660Left-hemisphere dorsal attention network to putamen white-matter structural connectivityGCST903027037.64
661DTI autoptx MD slf r tractGCST903852427.64
662FCRL6/KLRD1 ratioGCST903148077.63
663VSTM2B levelsGCST904710567.62
664Mean sphered cell volume (UKB data field 30270)GCST904680897.62
665BOLA2 or BOLA2B levelsGCST904684607.61
666DTI autoptx FA slf l tractGCST903851337.61
667Carboplatin drug response (IC50)GCST900117837.61
668STIP1 levelsGCST904707647.61
669CRACR2A/IRAG2 ratioGCST903142277.61
670Bifidobacterium catenulatum abundance in stoolGCST900322247.58
671Octadecenedioylcarnitine (C18:1-DC) levelsGCST901999707.57
672CASP10 levelsGCST904685427.56
673NFATC3 levelsGCST904700347.53
674Other intervertebral disc disordersFING000010637.52
675Scar conditions and fibrosis of skin (PheCode 701.2)GCST904761987.51
676DAPP1/ITGB1BP2 ratioGCST903143887.50
677FOXO3 levelsGCST904692667.48
678RIDA levelsGCST904704697.48
679Basophil countGCST900187267.46
680DTI TBSS MD Posterior limb of internal capsule LGCST903845917.45
681CDC27 levelsGCST904686647.44
682LCN2/PGLYRP1 ratioGCST903153067.42
683ITGB7 levelsGCST904696477.41
684Belief that own life is meaningful | Happiness and subjective well-beingUKBB000000907.41
685DTI TBSS L2 Superior longitudinal fasciculus LGCST903845177.40
686CDH17/SPINT1 ratioGCST903139447.40
687TNFRSF9 levelsGCST904709167.39
688CD27/TNFRSF13B ratioGCST903137777.37
689LRRC37A2 levelsGCST904698027.36
690TOR1AIP1 levelsGCST904709357.34
691General happiness | Happiness and subjective well-beingUKBB000002807.32
692EBAG9/TGFB1 ratioGCST903145707.30
693Suppurative and unspecified otitis mediaFING000013467.29
694MAVS/MED18 ratioGCST903153897.28
695Dried fruit consumptionGCST901329807.28
696HippSubfield lh volume GC-ML-DG-bodyGCST900026817.27
697CALCOCO1/CRACR2A ratioGCST903135987.27
698Strenuous sports or other exercisesGCST0061007.26
699BOC levelsGCST904684587.25
700GSTA4 levelsGCST902412837.23
701AMOTL2 levelsGCST904682947.23
702Takes medication for asthma?GCST904752607.23
703EBAG9/FKBP5 ratioGCST903145647.22
704Polymyalgia rheumaticaFING000011887.22
705Hair colour (natural, before greying) - Dark brown | Sun exposureUKBB000002977.22
706CD86 levelsGCST904686547.21
707PFKM levelsGCST906188027.21
708DTI TBSS L2 Posterior thalamic radiation RGCST903845047.20
709THBS2 levelsGCST904708547.18
710TNFRSF13B/TNFSF13B ratioGCST903159337.18
711ST13 levelsGCST904707517.18
712N-acetyl-1-methylhistidine levelsGCST902006907.16
713Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST906687587.16
714KCTD5 levelsGCST904696707.15
715Internal derangement of knee (PheCode 835)GCST904762827.14
716Hepatic cancerGCST900186387.13
717FOXO1/USP8 ratioGCST903148797.12
718HAVCR2 levelsGCST904215157.12
719DTI TBSS MD Superior longitudinal fasciculus LGCST903846137.12
720Volume of right cortical nucleusGCST904750337.11
721Treatment or medication use - insulin product (UKB data field 20003_1140883066)GCST900422267.11
722Omega-3 fatty acid levelsGCST905024227.11
723DTYMK levelsGCST904690497.08
724Malignant neoplasm, excluding all cancers (controls excluding all cancers)FING000007807.05
725FOXO1/MAP4K5 ratioGCST903148727.04
726CCL5/TACC3 ratioGCST903137077.03
727IDP dMRI ProbtrackX L1 str lGCST900042697.02
728LPCAT2/SERPINB8 ratioGCST903153286.99
729mean corpuscular hemoglobin (MCH, maximum, inv-norm transformed)GCST904754426.96
730Hair colour (natural, before greying): Dark brown (UKB data field 1747_4)GCST900418396.95
731TNFSF13B levelsGCST904709206.95
732Non-cancer illness year/age first occurred | Medical conditionsUKBB000005236.95
733KIR3DL1 levelsGCST904696876.95
734Other and unspecified psoriasisFING000009506.91
735T1 FreeSurfer aseg Right-PallidumGCST903841646.90
736EDAR/TACC3 ratioGCST903145896.90
737SLAMF1 levelsGCST904706496.88
738Omega-3 fatty acids to total fatty acids percentageGCST905020876.87
739GIMAP7 levelsGCST904693456.86
740SLITRK2 levelsGCST904706706.85
7415alpha-pregnan-3beta,20alpha-diol monosulfate (2) levelsGCST901998546.84
742Rheumatoid arthritis and other inflammatory (PheCode 714)GCST904762286.83
743Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)FING000010676.83
744TRAF3 levelsGCST904709576.82
745Eosinophil count varianceGCST905656896.81
746mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)GCST904754506.80
747Follicular lymphoma, hilmo (controls excluding all cancers)FING000005486.78
748Mean sphered cell volume | Blood countUKBB000004526.77
749Principal component-derived dietary pattern 26GCST901330316.77
750Tooth agenesis EXCLUDE clefts and syndromesFING000013686.76
751T1 CAT volume R RightThalamusGCST903840976.76
752VEGFB levelsGCST904710356.76
753mean corpuscular hemoglobin (MCH, mean, inv-norm transformed)GCST904754466.75
754DTI TBSS MD Cingulum cingulate gyrus LGCST903846076.75
755Medication use (immunosuppressants)GCST900187716.74
756SNX15 levelsGCST904706996.74
757EDAR/ERBIN ratioGCST903145756.73
758Red blood cell countGCST900187516.73
759LY96 levelsGCST904698236.73
760Chronic obstructive pulmonary disease in current smokersGCST900165936.72
761SRC/TBL1X ratioGCST903158846.71
762Destinations on discharge from hospital (recoded) - Usual Place of residence | Summary AdministrationUKBB000001676.70
763UNC5D levelsGCST904710106.69
764IDP dMRI TBSS L1 Retrolenticular part of internal capsule RGCST900040956.69
765Diseases of middle ear and mastoidFING000004276.66
766Methods of admission to hospital (recoded) - Elective admission: Booked | Summary AdministrationUKBB000004616.63
767CDKN2D/FOXO1 ratioGCST903139856.63
768Attendance/disability/mobility allowance - Disability living allowance | Other sociodemographic factorsUKBB000000586.63
769ESAM/FUT8 ratioGCST903147116.63
770Methods of discharge from hospital (recoded) - Discharged on clinical advice/consent | Summary AdministrationUKBB000004666.63
771SEMA4D levelsGCST904705736.59
772CD84/F2R ratioGCST903139126.59
773Types of physical activity in last 4 weeks - None of the above | Physical activityUKBB000008726.58
774FCRL5 levelsGCST904692086.57
775Dementia due to Parkinson's disease (more control exclusions)FING000003926.56
776DTI TBSS L3 Genu of corpus callosumGCST903845266.54
777IDP dMRI TBSS ISOVF Genu of corpus callosumGCST900044796.54
778Cerebral aneurysm, nonrupturedFING000002636.54
779GMPR2 levelsGCST904693676.51
780DTI autoptx L1 slf r tractGCST903851616.50
781Solitary pulmonary nodule (PheCode 514.2)GCST904760446.50
782AsthmaGCST900860476.50
783C1R levelsGCST904684936.49
784Ulcerative colitis, NASFING000013906.48
785AXIN1/MAVS ratioGCST903134146.48
786PRKAB1 levelsGCST904703246.47
787Current SmokerFING000003716.47
788Mean reticulocyte volumeGCST900023966.47
789UrticariaFING000014086.46
790DAB2/FKBP1B ratioGCST903143626.45
791MAP3K5/MAVS ratioGCST903153796.45
792Current employment status - Retired | EmploymentUKBB000001596.44
793Principal component-derived dietary pattern 42GCST901330476.44
794Athlete's foot (PheCode 110.12)GCST904755636.43
795Operative procedures - No procedure performed | Summary OperationsUKBB000005846.41
796Plasma N-acetyltaurine levels in chronic kidney diseaseGCST902656006.40
797Skin cancer | neoplasmsUKBB000007726.38
798DTI autoptx L1 cst l tractGCST903851476.37
799How are people in household related to participant - Husband, wife or partner | HouseholdUKBB000003306.37
800COX5B/GFER ratioGCST903142006.36
801GOPC/IRAK4 ratioGCST903149546.36
802CEP43/USP8 ratioGCST903140226.36
803JCHAIN levelsGCST904696616.35
804DTI TBSS L2 External capsule LGCST903845096.33
805PROK1 levelsGCST904703366.32
806DTI TBSS L3 Posterior thalamic radiation RGCST903845526.31
807Telomere length (principal component 1)GCST904351446.30
808Acquired hypothyroidism (PheCode 244.2)GCST904756506.29
809CXCL5/MESD ratioGCST903143506.28
810Ever SmokerFING000005226.28
811Mean reticulocyte volume (UKB data field 30260)GCST904680886.28
812CD300A levelsGCST904686196.28
813Percentage of fucosylation of monogalactosylated structures in total neutral plasma glycans (GP74)GCST906685186.27
814RAPGEF2 levelsGCST904704266.24
815Takes medication for Chronic lung diseases including COPD, Emphysema and Bronchitis?GCST904752736.23
816TNFSF12 levelsGCST902748466.23
817APBB1IP levelsGCST904683276.22
818N-acetylmethionine levelsGCST902002896.22
819Pregnenolone sulfate levelsGCST901998736.20
820N2-acetyl,N6,N6-dimethyllysine levelsGCST902006976.20
821TP53I3 levelsGCST904709376.20
822MAN2B2 levelsGCST904698446.20
823Snoring | SleepUKBB000007846.19
824DOK2/PDLIM7 ratioGCST903145356.18
825TRIM21 levelsGCST904709646.18
826Fruit intake (weighted GWA)GCST902672836.18
827PLAUR levelsGCST900120516.17
828COL1A1 levelsGCST902407446.17
829DNAJB2 levelsGCST904690136.17
830T1 FreeSurfer a2009s lh S postcentral areaGCST903847346.15
831Crohn's disease of large intestineFING000003686.14
832T1 FreeSurfer DKT rh supramarginal volumeGCST903843776.14
833WASL levelsGCST904710706.13
834ADAM12 levelsGCST904682166.12
835DCTN6/TDRKH ratioGCST903144366.11
836Mean corpuscular volume (UKB data field 30040)GCST904680866.11
837DTI autoptx FA ifo r tractGCST903851256.10
838Colitis, primary sclerosing, strict definitionFING000003136.10
839MED18/TACC3 ratioGCST903154146.09
840PEBP1 levelsGCST904702056.09
841CA3/HMBS ratioGCST903135846.09
842DTI TBSS MD Superior corona radiata RGCST903845966.08
843Peripheral enthesopathies and allied syndromes | musculoskeletalUKBB000006406.08
844F2R/TNFRSF14 ratioGCST903147396.06
845Non-cancer illness code, self-reported - hiatus hernia | Medical conditionsUKBB000005156.06
846NELL1 levelsGCST902424816.05
847IPCEF1/SPARC ratioGCST903151866.03
848Bread type - Wholemeal or wholegrain | DietUKBB000001076.01
849Lymphangioleiomyomatosis (sporadic)GCST0083115.99
850Cancer of bronchus; lung (PheCode 165.1)GCST904755735.99
851APEX1 levelsGCST904683295.99
852PSIP1 levelsGCST904703545.98
853Lung adenocarcinomaGCST0047445.98
854Neutrophill percentage (UKB data field 30200)GCST904680935.98
855Sources of admission to hospital (recoded) - Usual Place of residence | Summary AdministrationUKBB000007865.97
856T1 CAT volume R RightPutamenGCST903841015.97
857DTI TBSS MD Posterior thalamic radiation RGCST903846005.93
858Mean corpuscular volumeGCST900023925.92
859Loneliness, isolation | Mental healthUKBB000004085.91
860Mean spheric corpuscular volumeGCST900023975.91
861TNFSF12/TNFSF13 ratioGCST903159415.91
862KAZN levelsGCST904696665.90
863IDP T1 FIRST left hippocampus volumeGCST900024445.90
864TXNDC15 levelsGCST904709905.90
865F11R/SORT1 ratioGCST903147265.89
866CXCL5/PLXNA4 ratioGCST903143515.88
867Neutrophil percentage of white cellsGCST900023995.85
868FUT8/PDGFA ratioGCST903148905.84
869DLG4 levelsGCST904690015.84
870Cooked vegetable intake | DietUKBB000001475.84
871FASLG levelsGCST904691915.82
872Cleft hard palate NOSFING000003065.82
873POF1B levelsGCST904702815.80
874NT5C levelsGCST904700925.80
875Active to sedentary transition probabilityGCST900614295.77
876EFNA4/TNFRSF9 ratioGCST903146065.76
877CPXM1/HBEGF ratioGCST903142195.75
878CD40LG/TRAF2 ratioGCST903138285.75
879Actinic keratosisFING000000135.75
880TNFRSF19 levelsGCST900889475.75
881Dermatitis due to ingested foodFING000004035.74
882Uterine fibroidsGCST904619585.74
883CD58/MEGF10 ratioGCST903138535.74
884DTI autoptx L3 slf r tractGCST903852155.73
885Other non-epithelial cancer of skin | neoplasmsUKBB000006155.71
886Beta-hydroxyisovaleroylcarnitine levelsGCST901998025.70
887DTI TBSS L3 Superior corona radiata LGCST903845495.68
888Pilonidal cystFING000011675.67
889Intrinsic epigenetic age accelerationGCST900142905.65
890FUT8/TNFSF12 ratioGCST903148945.65
891CD69/EDAR ratioGCST903138755.65
892DNAJA2/PLXNA4 ratioGCST903145045.65
893HTRA2/SIAE ratioGCST903150975.65
894Atrophic disorders of skinFING000001295.64
895Neutrophill percentage | Blood countUKBB000004985.64
896HNRNPUL1 levelsGCST904694705.64
897DAG1/DBNL ratioGCST903143725.63
898BCR/ITGB1BP2 ratioGCST903134945.63
899CA1 levelsGCST904685105.63
900FUT8/VEGFC ratioGCST903148965.62
901PXN levelsGCST904703965.61
902Irritable bowel syndromeFING000007025.61
903ZNRD2 levelsGCST904711035.61
904Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020745.61
905Other malignant neoplasms of skin | Melanoma and other malignant neoplasms of skinUKBB000006135.60
906IPCEF1/TBCC ratioGCST903151885.58
907TBCA levelsGCST904708125.57
908Prescriptions - paracetamol | antipyreticUKBB000006965.56
909Prescriptions - antipyreticUKBB000006655.56
910Principal component-derived dietary pattern 21GCST901330265.56
911S100A12 levelsGCST904705135.55
912Other dorsopathies, not elsewhere classifiedFING000010415.55
913Educational attainmentGCST0025985.54
914Endometrial cancerGCST0064645.54
915FOXO1/IRAK4 ratioGCST903148705.53
916Operation code - hysterectomy | OperationsUKBB000005595.52
917DTI autoptx FA ifo l tractGCST903851245.50
918Dried fruit likingGCST900947565.49
919DBNL/EDAR ratioGCST903144165.49
920TNFRSF14/TNFSF14 ratioGCST903159365.48
921AHNAK levelsGCST904682615.48
922Back pain (PheCode 760)GCST904762665.45
923INSR levelsGCST904696235.45
924SUOX levelsGCST904707855.44
925Fluid intelligence score decline (difference score)GCST905658625.43
926Right-hemisphere visual network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903027765.42
927Epstein-Barr virus ZEBRA antibody levelsGCST900069015.42
928TACC3/TBC1D23 ratioGCST903159005.40
929Human herpes virus 7 U14 antibody levelsGCST900069095.39
930DTI autoptx MD fma tractGCST903852305.37
931BA-exvivo lh volume BA2GCST900028365.37
932SIRT1 levelsGCST904706415.37
933Left-hemisphere default mode network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903027625.37
934IL15/KLRD1 ratioGCST903151495.36
935Citrulline levelsGCST902004035.36
936Mean corpuscular volume | Blood countUKBB000004495.35
937Carcinoma in situ of breast, intraductal (controls excluding all cancers)FING000002405.35
938ENO3 levelsGCST904691115.34
939Other cancerGCST904751815.34
940Number of days/week walked 10+ minutes | Physical activityUKBB000005355.34
941Psoriatic arthritis vs Cutaneous psoriasisGCST902439575.34
942APP/HBEGF ratioGCST903133245.34
943mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed)GCST904754565.33
944Ulcerative colitisGCST904681525.32
945MINPP1 levelsGCST902419785.31
946Mean corpuscular hemoglobinGCST900023905.30
947LBR levelsGCST904697445.30
948TNFRSF4 levelsGCST904709135.29
949IGSF8/NECTIN2 ratioGCST903151405.29
950SERPINB13 levelsGCST904233265.28
951ADA levelsGCST904682315.28
952Avocado likingGCST900946945.27
953ENO2/HCLS1 ratioGCST903146605.27
954Urine GlcNAc sulfate conjugate of C21H34O2 steroid** levels in chronic kidney diseaseGCST902651755.26
955BleedingFING000002195.26
956Type 1 diabetesGCST900187055.26
957Acute bronchitisFING000000215.25
958DTI TBSS MD Cingulum cingulate gyrus RGCST903846065.25
959Ectopic pregnancyFING000004875.25
960Mean corpuscular hemoglobin varianceGCST905656935.24
961GP6/HPCAL1 ratioGCST903149635.24
962SPTLC1 levelsGCST904271305.24
963All pneumoniaeFING000000655.23
964DSG3/NECTIN4 ratioGCST903145605.22
965Trouble falling asleep when you first go to bedGCST904763855.21
966Type 1 diabetes with ophthalmic manifestations (PheCode 250.13)GCST904756635.21
967T1 CAT volume L VIIIaGCST903841275.21
968Left-hemisphere somatomotor network to left-hemisphere control network white-matter structural connectivityGCST903026735.21
969AHSP/BLVRB ratioGCST903132145.21
970CCN2/TACC3 ratioGCST903137175.20
971CD20 on IgD- CD27- B cellGCST900017545.20
972Hernia abdominopelvic cavityGCST900860875.20
973Tryptophan betaine levelsGCST901998195.19
974SNAP23/TXLNA ratioGCST903158575.18
975NAP1L4 levelsGCST904699985.16
976IL2RA/NCR1 ratioGCST903151615.14
977CIAPIN1/SNX9 ratioGCST903140685.14
978F2R levelsGCST904691685.12
979Left-hemisphere dorsal attention network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903026975.11
980DTI autoptx L3 ilf l tractGCST903852075.11
981CDKN2D/TACC3 ratioGCST903139925.10
982CD244/GP1BA ratioGCST903137665.10
983Malignant neoplasm of kidney, except pelvis (PheCode 189.11)GCST904755975.09
984F5 levelsGCST904464665.09
985Red blood cell countGCST900023645.09
986CLEC4D/CLEC6A ratioGCST903141095.08
987Bread type: Wholemeal or wholegrain (UKB data field 1448_3)GCST901329665.08
988BAG6/BMP6 ratioGCST903134505.08
989KYNU/SCLY ratioGCST903152655.08
990ELOA levelsGCST904691045.07
991PIKFYVE levelsGCST904702355.07
992DTI TBSS L1 Anterior corona radiata RGCST903844505.07
993Principal component-derived dietary pattern 12GCST901330175.07
994Tobacco use disorder | mental disordersUKBB000008245.06
995EBAG9/TBCC ratioGCST903145685.05
996DTI autoptx L1 cst r tractGCST903851485.05
997PARP1 levelsGCST904701605.05
998SIGLEC1/SSC5D ratioGCST903158445.05
999PSME2 levelsGCST904703615.05
1000DNAJC9 levelsGCST904690185.04